Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Stability enhancement

There are some special cases where tetrahedral intermediates are unusually stable there are three phenomena which lead to this stability enhancement. The first is an unusually reactive carbonyl (or imine) compound which is very prone to addition. An example of such a compound is trichoroacetaldehyde or chloral, for which the covalent hydrate can be isolated. A simple way to recognize such compounds is to think of the carbonyl group as a (very) stabilized carbocation, bearing an substituent. [Pg.8]

Encapsulation via the layer-by-layer assembly of multilayered polyelectrolyte (PE) or PE/nanoparticle nanocomposite thin shells of catalase in bimodal mesoporous silica spheres is also described by Wang and Caruso [198]. The use of a bimodal mesoporous structure allows faster immobilization rates and greater enzyme immobilization capacity (20-40 wt%) in comparison with a monomodal structure. The activity of the encapsulated catalase was retained (70 % after 25 successive batch reactions) and its stability enhanced. [Pg.467]

A stability enhancement in methanol of about 104 occurs for the potassium complex of 18-crown-6 (169) compared to its non-macrocyclic analogue (223) in methanol (Frensdorff, 1971 Petersen Frensdorff, 1972) (Figure 6.3). A comparative study of this and the corresponding... [Pg.183]

NT-VS2 is not the only example of stabilization of particular compositions in IF and NT phases. Enhanced stability is shown by Na-intercalated IF-MoS2,300 Ag- and Au-intercalated coaxial nanotubes MoS2 and WS2.301 The reason of the stability enhancement is probably related to the fact that the IF and NT structures are always closed and no reactive edges are exposed to the hostile environment. [Pg.528]

In the homogenous mixture of Starch and Polyvinyl alcohol (PVA), 30 % of plasticizer was mixed to make Pure blend. Then 10 % cellulose was mixed into above mixture followed by removal of extra water gave Cellulose-Reinforced starch-PVA blends. The different proportions of Fly ash were mixed into mixture of Cellulose-Reinforced starch-PVA blends to get various fly ash inserted Cellulose-Reinforced starch-PVA blends. Solubility, swelling behaviour and water absorption studies of Fly ash blends were measured at different time intervals at relative humidity of 50-55%. The insertion of Cellulose into starch-PVA blend decreases the solubility of blends due to the hydrophobicity of cellulose, but the solubility further increases by insertion of Fly ash into starch-PVA matrix that indicating the mechanical stability enhancement of blends. The water absorption behaviour of fly ash blends increases rapidly upto 150 min and then no change. The optimum concentration of Fly ash into Cellulose-Reinforced starch-PVA blend was 4%. [Pg.117]

To avoid the problem of chirality and to improve the potency and limit the non-specific actions of AS-ODN, new compounds are required. Synthesis of new AS-ODNs has further improved their nuclease stability, enhanced of cellular uptake and affinity through modification of the base, sugar and phosphate moieties of the oligonucleotides [105-108],... [Pg.146]

The chelate formation in lithium complexes 17 or 20 contributes to stabilization. Enhancement of kinetic acidity arises from the formation of pre-complexes 16 and 19, respectively. Here, already a dipole is induced and, in addition, proton exchange can proceed intramolecularly via a five- or six-membered ring. Despite these favourable features, the acidity of alkyl carbamates 15 is lower than those of the 1-proton in butane n-BuLi does not lead to deprotonation. In order to suppress carbonyl attack, a branched amino residue NR2 such as diisopropylamino (in Cb) or 2,2,4,4-tetramethyl-l,3-oxazolidin-3-yl (in Cby) is essential. A study on the carbenoid nature of compounds 17 was undertaken by Boche and coworkers. ... [Pg.1061]

Recovery is sufficiently rapid with most intravenous drugs to permit their use for short ambulatory (outpatient) surgical procedures. In the case of propofol, recovery times are similar to those seen with sevoflurane and desflurane. Although most intravenous anesthetics lack antinociceptive (analgesic) properties, their potency is adequate for short superficial surgical procedures when combined with nitrous oxide or local anesthetics, or both. Adjunctive use of potent opioids (eg, fentanyl, sufentanil or remifentanil see Chapter 31) contributes to improved cardiovascular stability, enhanced sedation, and perioperative analgesia. However, opioid compounds also enhance the ventilatory depressant effects of the intravenous agents and increase postoperative emesis. Benzodiazepines (eg, midazolam, diazepam) have a slower onset and slower recovery than the barbiturates or propofol and are rarely used for induction of anesthesia. However, preanesthetic administration of benzodiazepines (eg, midazolam) can be used to provide anxiolysis, sedation, and amnesia when used as part of an inhalational, intravenous, or balanced anesthetic technique. [Pg.550]

Polymer-stabilized Au NPs have been the object of intense research in recent years because, apart from their intrinsic synthetic interest, these hybrid materials have interesting properties and potential applications. There are also several advantages in the use of polymers as stabilizers enhancement of long-term stability adjustment of solubility or amphiphilicity of nanoparticles, tuning of the properties of Au NPs, and the promotion of compatibility and processability. [Pg.149]

Homogeneous a-hydroxyalkyl complexes, L MCH(R)OH, have been proposed as catalytic intermediates in the conversion of CO-H2 gas mixtures to oxygen-containing organic molecules.1 However, isolable examples of metal a-hydroxyalkyl complexes are scarce.2 We have discovered that incorporation of the a-hydroxyalkyl moiety into a metallacycle provides a marked stability enhancement.3... [Pg.169]

J. Kim, K. Lee, K. Lee, J. Bae, J. Yang, and S. Hong, Studies on the thermal stabilization enhancement of ABS synergistic effect of triphenyl phosphate nanocomposite, epoxy resin, and silane coupling agent mixtures, Polym. Degrad. Stab., 79(2) 201-207, 2003. [Pg.262]

Following immobilisation, the beads were dispersed in an aqueous solution of HEC and cast onto Pt electrodes. Activity tests showed that leaching of immobilised enzyme was 2.5 times slower than that of free enzyme dispersed in HEC. Comparisons of activity to acetylthiocholine after 72 h constant operation showed a large stability enhancement for enzymes immobilised on both silica and carbon when compared to dispersion in HEC [36]. [Pg.316]

The design of salt forms of prodrugs is associated most commonly with solubility and stability enhancement in various dosage forms. Ester prodrugs often are converted to salts to provide the desired balance of hydrophilic/lipophilic properties.45... [Pg.84]

Towards Larger Proteins by Nonuniform Labeling and Stability Enhancement... [Pg.124]

Figure 5,20 Portion of a 3D X-filtered NOESY spectrum of uniformly 13C/15N-labeled, stability-enhanced kinaseX in complex with kinaseX inhibitor 2. The protein and inhibitor concentrations used were 300 pM. The F3 (inhibitor1H) plane is at 7.83 ppm. Peaks with protein resonance assignments are labeled. (Note Val-A and Val-B refer to the y-i and y methyl, respectively of the same valine residue.) The spectrum was recorded at 35 °C, 600 MHz 1H frequency using a NOESY mixing time of 100 ms on a Varian Inova spectrometer equipped with a Cold Probe. The spectrum is aliased in the 13C (F2) dimension. Figure 5,20 Portion of a 3D X-filtered NOESY spectrum of uniformly 13C/15N-labeled, stability-enhanced kinaseX in complex with kinaseX inhibitor 2. The protein and inhibitor concentrations used were 300 pM. The F3 (inhibitor1H) plane is at 7.83 ppm. Peaks with protein resonance assignments are labeled. (Note Val-A and Val-B refer to the y-i and y methyl, respectively of the same valine residue.) The spectrum was recorded at 35 °C, 600 MHz 1H frequency using a NOESY mixing time of 100 ms on a Varian Inova spectrometer equipped with a Cold Probe. The spectrum is aliased in the 13C (F2) dimension.
Adjunctive use of potent opioids (eg, fentanyl and related compounds) contributes cardiovascular stability, enhanced sedation, and profound analgesia. Other intravenous agents such as the benzodiazepines (eg, midazolam, diazepam) have slower onset and recovery features and are rarely used for induction of anesthesia. However, preanesthetic administration of benzodiazepines can be used to provide a basal level of sedation and amnesia when used in conjunction with other anesthetic agents. [Pg.599]

In the present report we address questions regarding the structural stability of EcaL-ASNase. The results of the present work form the basis for a rational design of new engineered forms of EcaL-ASNase with enhanced thermal stability. Enhancement of enzyme s thermostability is of particular importance to the processes of production, storage, and therapeutic use. This would result in more efficient enzyme variants that would be able to exhibit their therapeutic efficacy in a lower dose, thereby minimizing their toxic effects to patients. [Pg.331]

West WC, Whitacre JF, Lim JR. Chemical stability enhancement of lithium conducting solid electrolyte plates using sputtered LiPON thin films. J Power Sources. 2004 126(1-2) 134-8. [Pg.245]

One of the critical factors in excipient selection and concentration is the effect on preferential hydration of the biopharmaceutical product [53, 54], Preferential hydration refers to the hydration layers on the outer surface of the protein and can be utilized to thermodynamically explain both stability enhancement and denatur-ation. Typical excipients used in protein formulations include albumin, amino acids, carbohydrates, chelating and reducing agents, cyclodextrins, polyhydric alcohols, polyethylene glycol, salts, and surfactants. Several of these excipients increase the preferential hydration of the protein and thus enhance its stability. Cosolvents need to be added in a concentration that will ensure their exclusion from the protein surface and enhance stability [54], A more comprehensive review of excipients utilized for biopharmaceutical drug products is available elsewhere [48],... [Pg.20]


See other pages where Stability enhancement is mentioned: [Pg.955]    [Pg.143]    [Pg.302]    [Pg.247]    [Pg.20]    [Pg.138]    [Pg.15]    [Pg.262]    [Pg.320]    [Pg.146]    [Pg.84]    [Pg.127]    [Pg.129]    [Pg.389]    [Pg.175]    [Pg.394]    [Pg.118]    [Pg.215]    [Pg.7]    [Pg.237]    [Pg.372]    [Pg.518]    [Pg.172]    [Pg.250]    [Pg.1776]    [Pg.309]    [Pg.40]   
See also in sourсe #XX -- [ Pg.34 , Pg.35 , Pg.36 , Pg.37 , Pg.38 ]




SEARCH



Enhanced stability

© 2024 chempedia.info